MPXOFMPX International Corporation

About MPX International Corporation (MPXOF)

MPX International Corporation (MPXOF) is a Drug Manufacturers - Specialty & Generic company headquartered in Toronto, ON, Canada whose shares trade over-the-counter on the Expert Market tier.

MPX International Corporation is a multinational diversified cannabis company focused on developing and operating assets across the international cannabis industry with an emphasis on cultivating, manufacturing and marketing products which include cannabinoids as their primary active ingredient. With current operations spanning four continents in Canada, Switzerland, South Africa, Malta, Thailand and Australia as well as evolving partnership and distribution opportunities in other jurisdictions, MPXI continues to position itself as an emergent global participant in the cannabis industry.

Products and services

Developing and operating assets across the global cannabis industry with an emphasis on cultivating, manufacturing and marketing products which include cannabinoids as their primary active ingredient.

MPXOF key facts

Ticker symbol

MPXOF

Market tier

Expert Market

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Toronto, ON, Canada

Country of incorporation

CA

Year of incorporation

2018

Employees

65

Estimated market cap

$14.2K (as of Apr 16, 2025)

Shares outstanding

141,649,163

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

9/30

Latest filing

Interim Financial Report (Mar 31, 2022)

MPX International Corporation leadership

• William Scott Boyes — CEO, President
• Jeremy Steven Budd — EVP, General Counsel, Corporate Secretary
• Jonathan Chu — VP, Fin. & Acct.
• Andrea de Donato — Legal Counsel

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with M